How We Research, Source, and Publish

Purpose

We publish research-grade content about peptides used in scientific investigation. The information must be accurate, sourced, and useful to researchers planning protocols. This page describes the editorial standards we hold ourselves to — covering how we select sources, how we scope compliance claims, how we ensure originality, and how we correct errors when they occur.

Source Hierarchy (Citations Policy)

All factual claims in our published content are sourced according to the following hierarchy, applied in order of authority:

• —Peer-reviewed clinical trials (NIH ClinicalTrials.gov, primary literature)
• —FDA / EMA labeling and pharmacopoeia entries
• —Independent meta-analyses (Cochrane, peer-reviewed systematic reviews)
• —ISO 17025 lab analytical methods (HPLC, mass spectrometry standards)
• —Manufacturer COAs — in our case, Janoshik Analytical reports tied to specific batch numbers

We do not cite anonymous bodybuilding forums, undated supplement-marketing pages, or AI-generated rehashes of primary literature.

Compliance Scope

Every peptide we describe is a research compound intended for in vitro and preclinical investigation only. We do not make medical claims, do not provide dosing guidance for human use, and do not represent any product as a drug, supplement, or treatment. “For research purposes only” (RUO) is a hard editorial rule, not a marketing tag. Any published content that could be read as directing therapeutic use is considered an editorial error and is subject to the correction policy below.

Originality & Provenance

Research monographs published on this site are written from primary sources, not aggregated or paraphrased from other supplier blogs. When a study or clinical trial is cited, it carries a DOI or PMID so readers can verify the source directly. When a quantitative claim is made — purity percentage, molecular weight, half-life, binding affinity — it ties back to either a specific peer-reviewed trial or our own COA database (Janoshik Analytical batch records). We do not repeat claims we cannot trace.

Correction Policy

If a published article contains an error, we correct it inline and add a note at the bottom of the page indicating what changed and when. Substantive corrections — those affecting a factual claim, dosage figure, or safety characterisation — also update the dateModified structured-data field on that page. To report a suspected error, contact support@certapeptides.com with the URL and the disputed claim. We respond within five business days.